Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Awiqli (Insulin Icodec) is a next-generation, once-weekly basal insulin analog developed to improve adherence and simplify insulin therapy in adult patients with diabetes. By maintaining stable insulin levels over seven days, Awiqli helps minimize glucose fluctuations and reduces the burden of daily injections. This innovative formulation supports improved lifestyle flexibility for those managing type 1 or type 2 diabetes. Many patients seeking to buy Awiqli find its weekly dosing schedule to be a major benefit compared to conventional basal insulins. Its unique molecular design provides prolonged activity, ensuring a consistent glucose-lowering effect throughout the week.
| Fact Table | |
|---|---|
| Formula | C267H404N64O76S6 |
| License | FDA approved (March 2024) |
| Bioavailability | ~80% (subcutaneous) |
| Legal status | Prescription only (Rx) |
| Chemical Name | Insulin icodec |
| Elimination half-life | ~196 hours (approx. 8 days) |
| Dosage (Strength) | 700 units/mL in pre-filled pens |
| Pregnancy | Consult healthcare provider |
| Brands | Awiqli |
| Protein binding | Low; similar to human insulin |
| PubChem CID | 162199366 |
| MedlinePlus | Not assigned |
| ChEBI | Not listed |
| ATC code | A10AE09 |
| DrugBank | DB16612 |
| KEGG | D12623 |
| Routes of administration | Subcutaneous injection |
Administer Awiqli once per week via subcutaneous injection, preferably on the same day each week. Injection sites include the abdomen, thigh, or upper arm, with rotation recommended to reduce the risk of lipodystrophy. Dosage initiation and adjustments should be based on clinical assessment, previous insulin use, and individual blood glucose profiles. When transitioning from another basal insulin, careful planning is required to avoid overlapping effects or hypo-/hyperglycemia. Patients using Awiqli insulin should be instructed thoroughly in proper handling and administration techniques.
Awiqli contains 70 U/mL of insulin icodec, a modified long-acting insulin analog. Additional components include zinc chloride, glycerol, phenol, and water for injection. The solution is sterile, clear, and preservative-free beyond the listed excipients.
Awiqli requires careful initiation, especially in individuals with compromised hepatic or renal function, or when switching from daily insulin therapy. Hypoglycemia risk remains a concern and may be amplified by delayed or missed meals, unplanned physical activity, or incorrect dosing. Patient education and regular monitoring are essential. Insurance coverage may vary, and individuals concerned about Awiqli price should consult their healthcare provider or pharmacy for cost-effective access options.
Do not use Awiqli in patients with known hypersensitivity to insulin icodec or its components. It is also contraindicated during active episodes of hypoglycemia. The safety of Awiqli has not been evaluated in children or in the setting of diabetic ketoacidosis.
Reported side effects of Awiqli may include:
Immediate medical attention is required for any signs of severe allergic reaction or hypoglycemia.
What is Awiqli (insulin icodec)?
Awiqli is a once-weekly basal insulin analog used to improve glycemic control in adults with diabetes mellitus. It has a longer half-life than daily insulins, allowing for weekly rather than daily injections.
How is Awiqli administered?
Awiqli is administered as a subcutaneous injection once weekly, on the same day each week. It can be injected into the abdomen, thigh, or upper arm.
Can I switch from my daily insulin to Awiqli?
Yes, you can switch from daily insulin to Awiqli under your healthcare provider's guidance. They will provide specific instructions for transitioning and adjusting your dosage.
What are the most common side effects of Awiqli?
Common side effects include hypoglycemia (low blood sugar), injection site reactions, headache, and nausea. As with all insulins, hypoglycemia is the most significant potential side effect.
How should Awiqli be stored?
Unopened Awiqli should be stored in a refrigerator between 36°F to 46°F (2°C to 8°C). Once in use, it can be kept at room temperature (below 86°F/30°C) for up to 4 weeks.
What should I do if I miss a dose of Awiqli?
If you miss a dose, administer it as soon as possible within 3 days after the missed dose. If more than 3 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day.
Can Awiqli be used with other diabetes medications?
Yes, Awiqli can be used in combination with other diabetes medications, including oral antidiabetic drugs and mealtime insulins, as prescribed by your healthcare provider.
How long does it take for Awiqli to start working?
Awiqli has a gradual onset of action. It can take several weeks to reach steady-state levels in the body and achieve optimal blood glucose control.
Do I need to monitor my blood sugar differently when using Awiqli?
You should continue regular blood glucose monitoring as directed by your healthcare provider. More frequent monitoring may be recommended during the transition period to Awiqli.
Is Awiqli suitable for patients with type 1 and type 2 diabetes?
Awiqli is approved for use in adults with both type 1 and type 2 diabetes mellitus who require basal insulin for glycemic control.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews